The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
And if it goes up another 30% tomorrow, then who’s the idiot! Cannot understand people who sell too quickly knowing the strong possibility of positive news just around the corner.
Https://www.uq.edu.au/news/article/2023/03/clinical-trial-success-psoriasis-drug
15 March 2023
A company launched from The University of Queensland’s Institute for Molecular Bioscience (IMB) has passed an important milestone in developing an oral treatment for the common skin disease psoriasis.
Protagonist Therapeutics was spun out of work by Associate Professor Mark Smythe to develop new drugs for conditions previously only treated with injectables.
The company, in collaboration with Janssen Biotech, has reported that patients in a Phase 2b clinical trial who took the drug candidate JNJ-2113 had a 75 per cent improvement in their plaque psoriasis compared to those who received a placebo.
The original Parker tweet was logged at 10.39hrs on the 18th. The later tweet was logged 14hours later, hence my football comment. Yes, I made a comment and then get crucified by idiots. Must be that time of the month. Move on!